Cannabinoids and interleukin-6 enhance the response to NMDA in developing CNS neurons.
Gruol
D L
DL
Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California 92037, USA.
Netzeband
J G
JG
Qiu
Z
Z
Campbell
I L
IL
Parsons
K L
KL
D000818:Animals; D001921:Brain / Q000196:embryology / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism*; D002186:Cannabinoids / Q000378:metabolism / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D004347:Drug Interactions; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology*; D015850:Interleukin-6 / Q000378:metabolism / Q000494:pharmacology*; D051379:Mice; D008822:Mice, Transgenic; D016202:N-Methylaspartate / Q000494:pharmacology*; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects
D002186:Cannabinoids; D018690:Excitatory Amino Acid Agonists; D015850:Interleukin-6; D016194:Receptors, N-Methyl-D-Aspartate; D016202:N-Methylaspartate; D002118:Calcium